Sciuker Frames, strong growth in 2022 results. Outlook confirmed

Sciuker Frames strong growth in 2022 results Outlook confirmed

(Tiper Stock Exchange) – Sciuker Framesa group listed on Euronext Growth Milan and active in the production of eco-sustainable windows and in the implementation of energy requalification interventions, closed the 2022 with a production value consolidated equal to 193.8 million euros (+88.3% compared to 31 December 2021, which recorded 102.9 million euros and which exceeds the target communicated in the Business Plan Update on 25 October 2022 and equal to 175 million euros) and a Adjusted EBITDA consolidated value of 43.2 million euros (+50% compared to 31 December 2021, which recorded 28.8 million euros and +1.6% compared to the 42.5 million euro target contained in the Updated Business Plan). The Net income consolidated amounted to approximately 20.7 million euro, an increase of 38.8%.

The value of net financial position as at 31 December 2022 was equal to -1.4 million euros (cash positive), an improvement compared to the value of 2.1 million euros (cash negative) recorded at 31 December 2021.

“It is a huge satisfaction for me and for all the management to be able to present these extraordinary results – commented theAD Marcus Cyprian – The growth we have achieved is not common, especially in industrial groups such as the SCK Group”.

“My enthusiasm is even greater considering that the increase in performance in recent years derives from a well balanced mix between acquisitions and organic growth – he added – On the one hand we have ascertained that incorporating other companies into the group represents a booster to the speed of growth even though it requires a lot of work to integrate them and bring them to a growth rate in line with the other companies; on the other hand we have learned the importance of balancing production and therefore how essential it is to continue investing in production efficiency as well as in R&D and design”.

The Board of Directors has Outlook 2023 confirmedwhich forecasts a consolidated value of production of approximately 224 million euros and a consolidated adjusted EBITDA of approximately 55.4 million euros.

tlb-finance